Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05847751 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

Study acronym: BSC07
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Apr 2026 → May 31, 2026
See other at-risk trials from Ceric Sàrl

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Apr 2026 to May 31, 2026
    • Study completion pushed from May 2026 to Jul 2026
    v7
  2. Primary completion date: Dec 2025 to Apr 2026
    • Study completion date: Dec 2025 to May 2026
    v6
  3. Trial status: Recruiting to Active, Not Recruitingv5 Show 4 more changesShow less
    • Enrollment target: estimated 100 to confirmed 51
    • Primary completion date: Jun 2026 to Dec 2025
    • Study completion date: Dec 2026 to Dec 2025
    • Site details revised at 7 of 7 sites
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Jun 2025 to Jun 2026
    • Study completion date: Dec 2025 to Dec 2026
    • Start date changed from estimate of Jan 2024 to Mar 6, 2024
    • Site details revised at 7 of 7 sites
  5. Primary completion date: Sep 2024 to Jun 2025
    • Start date: Jul 2023 to Jan 2024
    • Study completion date: Sep 2024 to Dec 2025
    v3
  6. Study title shortened, about 5 wordsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ceric Sàrl
10 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
The objective of this study is to evaluate the ACURATE Neo2 in the Middle East population with severe, symptomatic aortic stenosis.
Trial Details
NCT Number NCT05847751
Lead Sponsor Ceric Sàrl
Collaborators: European Cardiovascular Research Center
Conditions
(from sponsor)		 Severe Aortic Valve Stenosis
Related terms Aortic Valve Stenosis
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov